Cutaneous aspergillosis is very rare and occurs predominantly in immunocompromised patients including transplant recipients. We report a 26-year-old male with acute lymphoblastic leukemia who developed cutaneous aspergillosis after undergoing combined immunosuppressive treatment including corticosteroid, cyclosporine A, mychophenolate mofetil and mesenchymal stem cells for steroid refractory skin acute graft versus host disease after myeloablative haematopoietic stem cell transplantation. The patient was treated with oral voriconazole therapy and recovered partially.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
cutaneous aspergillosis
12
acute lymphoblastic
8
lymphoblastic leukemia
8
stem cell
8
isolated cutaneous
4
aspergillosis acute
4
leukemia patient
4
patient allogeneic
4
allogeneic stem
4
cell transplantation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!